Literature DB >> 30530076

The synthesis and anticancer activities of chiral epoxy-substituted chromone analogs.

Hyunji Jo1, Seung Hee Seo1, Younghwa Na2, Youngjoo Kwon3.   

Abstract

Human DNA topoisomerases (topos) have been recognized as a good target molecule for the development of anticancer drugs because they play an important role in solving DNA topological problems caused by DNA strand separation during replication and transcription. In this study, we designed and synthesized 11 novel chromone backbone compounds possessing epoxy and halohydrin substituents with chirality. In the topos inhibition test, compounds 2, 9, 10, and 11 showed comparable topo I inhibitory activity at concentration of 100 μM compared to camptothecin, and all of the synthesized compounds showed moderate topo IIα inhibitory activity. Among them, compounds 9, 10 and 11 were more potent than the others in both topo I and IIα inhibitory activity. Compound 11 showed the most potent cell antiproliferative activity against all tested cancer cell lines with particularly strong inhibition (an IC50 of 0.04 µM) of K562 myelogenous leukemia cancer cell proliferation. In the brief structure-activity relationship analysis, there was no clear correlation between stereochemistry and topos inhibitory and cytotoxic activity. 5(R),7(S)-bisepoxy-substituted compound 11 was the most potent DNA cross-linker and induced G2/M arrest in a cell cycle assay in a dose- and time-dependent manner. After the treatment time period induced apoptosis in K562 cells without increasing G2/M-phase cells. Overall, compound 11 showed good consistent inhibitory biological activity related to cancer cell proliferation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30530076     DOI: 10.1016/j.bioorg.2018.11.054

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  5 in total

Review 1.  Oxygen- and Sulphur-Containing Heterocyclic Compounds as Potential Anticancer Agents.

Authors:  Harshita Sachdeva; Sarita Khaturia; Mohammad Saquib; Narsingh Khatik; Abhinav Raj Khandelwal; Ravina Meena; Khushboo Sharma
Journal:  Appl Biochem Biotechnol       Date:  2022-07-28       Impact factor: 3.094

2.  Novel Epoxides of Soloxolone Methyl: An Effect of the Formation of Oxirane Ring and Stereoisomerism on Cytotoxic Profile, Anti-Metastatic and Anti-Inflammatory Activities In Vitro and In Vivo.

Authors:  Oksana V Salomatina; Aleksandra V Sen'kova; Arseny D Moralev; Innokenty A Savin; Nina I Komarova; Nariman F Salakhutdinov; Marina A Zenkova; Andrey V Markov
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

3.  Synthesis of Palladium(II) Complexes via Michael Addition: Antiproliferative Effects through ROS-Mediated Mitochondrial Apoptosis and Docking with SARS-CoV-2.

Authors:  Jebiti Haribabu; Swaminathan Srividya; Dharmasivam Mahendiran; Dasararaju Gayathri; Vemula Venkatramu; Nattamai Bhuvanesh; Ramasamy Karvembu
Journal:  Inorg Chem       Date:  2020-11-24       Impact factor: 5.165

4.  Novel Thiochromanone Derivatives Containing a Sulfonyl Hydrazone Moiety: Design, Synthesis, and Bioactivity Evaluation.

Authors:  Lu Yu; Jiyan Chi; Lingling Xiao; Jie Li; Zhangfei Tang; Shuming Tan; Pei Li
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

5.  Design and synthesis of heterocyclic azole based bioactive compounds: Molecular structures, quantum simulation, and mechanistic studies through docking as multi-target inhibitors of SARS-CoV-2 and cytotoxicity.

Authors:  Jebiti Haribabu; Vasavi Garisetti; Rahime Eshaghi Malekshah; Swaminathan Srividya; Dasararaju Gayathri; Nattamai Bhuvanesh; Ramalinga Viswanathan Mangalaraja; Cesar Echeverria; Ramasamy Karvembu
Journal:  J Mol Struct       Date:  2021-10-21       Impact factor: 3.196

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.